Evaluation on efficacy and safety of capecitabine plus docetaxel versus docetaxel monotherapy in metastatic breast cancer patients pretreated with anthracycline: Randomized phase III study (JO21095)

Status: Active, no longer recruiting

Phase of Trial: Phase III

Latest Information Update: 02 Jan 2018

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

17 Jan 2013 New trial record
08 Dec 2012 Analysis of the overall survival data is under examination according to the abstract presented at the 35th Annual San Antonio Breast Cancer Symposium.
08 Dec 2012 Results of an analysis on the effect of circulating tumour cells on response were presented at the 35th Annual San Antonio Breast Cancer Symposium.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com